NFKB1 and Miyoshi myopathy: Based on model simulations (figure 10), the GADD45β-targeted therapy is suggested to be more sensitive than the NF-κB-targeted therapy as it can produce a greater suppression of MM cells than IKK inhibition when each are suppressed to the same degree.